Drug Interaction Between Butalbital and Acyclovir

Mechanism and Safety Profile

• Butalbital is a short- to moderate-duration barbiturate that works via GABA receptors and does not share metabolic pathways with acyclovir 1
• Butalbital is habit-forming and can lead to tolerance, dependence, and withdrawal seizures with chronic use 1

Critical Clinical Considerations

• The American Academy of Neurology recommends that butalbital-containing medications should be limited to no more than twice weekly to prevent medication-overuse headache 2
• Daily migraines while using butalbital indicate treatment failure and warrant immediate adjustment of therapy 2
• Regular assessment for butalbital overuse patterns is essential, as frequent use perpetuates chronic daily headaches 2

Common Pitfalls to Avoid

• The American Headache Society advises against assuming butalbital is safe for frequent use—it carries significant risks of medication-overuse headache, tolerance, and dependence that can worsen migraine patterns 2
• The American Academy of Neurology recommends considering preventive therapy if acute medications are being used more than twice weekly 3